Zum Inhalt

Correction to: Elucidation of the mechanism of amyloid A and transthyretin formation using mass spectrometry-based absolute quantification

  • Open Access
  • 11.08.2023
  • Correction
Erschienen in:
download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
The original article can be found online at https://doi.org/10.1007/s00428-023-03591-w.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Correction to: Virchows Archiv
The image presented in Figure 2 of the published version of the above article was incorrect. The corrected Figure 2 is shown as follows:
Fig. 2
Amino acid sequence, quantitative value of human transthyretin (TTR) peptides and schema of folding TTR based on previously reported data [7]. A. Transthyretin (TTR) consists of 127 amino acids. In a previous report using the cryo-EM [7], peptides aa 11–123 were detected (solid underlined) and 35–57 were not (dotted underlined). Two peptides, aa 22–34 (black and bold) and aa 36–48 (red and bold), which were detected using absolute quantification by LC–MS in our previous study [2] are enclosed in the boxes. B. We used two specimens from each patient: cardiac tissue (n = 9) and another organ (n = 7); however, two ATTR cases were excluded because the amount of deposition in organs other than the heart was too small (cases 15, 16). The bar graph shows the average of three measurements. In our quantification study, two tryptic peptides; aa 22–34 and aa 36–48 of TTR were successfully. Both fragments were detected in 47 of 48 samples, with an average aa 36–48/aa 22–34 ratio of 10.26% (2.45%–26.67%).The original data can be found in “Supporting information (S3 Table)” in reference [2]. C. This early fibril state consists of full-length TTR and contains the low amyloidogenic segment at aa 36–56 (including red part). Quantitative values of aa 36–48 indicated mature ATTR amyloid fibrils are 9 times more present than the early fibril state
Bild vergrößern
The original article has been corrected.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
download
DOWNLOAD
print
DRUCKEN
Titel
Correction to: Elucidation of the mechanism of amyloid A and transthyretin formation using mass spectrometry-based absolute quantification
Verfasst von
Yukako Shintani-Domoto
Koji L. Ode
Seitaro Nomura
Hiroyuki Abe
Hiroki R. Ueda
Takashi Sakatani
Ryuji Ohashi
Publikationsdatum
11.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 5/2024
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-023-03617-3

Neu im Fachgebiet Pathologie

Lymphome des Thymus und Mediastinums

Lymphozytenreiche Läsionen machen den Großteil der relevanten Differentialdiagnosen im vorderen Mediastinum aus und umfassen nichtneoplastische und neoplastische Entitäten. Lymphome stellen darunter mit ca. 10–15 % der Fälle eher einen kleinen …

Kombinationslymphome, Grauzonenlymphome und künftige Herausforderungen

Lymphome werden grundlegend in Hodgkin-Lymphome und B‑ und T‑Zell-Lymphome eingeteilt. Ihre Diagnostik beruht auf morphologischen, immunhistochemischen und zunehmend molekularen Methoden. Das klassische Hodgkin-Lymphom ist durch …

KI in der Diagnostik – aus Sicht der Pathologie

Die zunehmende Komplexität und Individualisierung onkologischer Diagnostik und Therapie stellt die Pathologie vor neue Herausforderungen. Gleichzeitig entwickelt sich die Künstliche Intelligenz (KI) von einer Zukunftstechnologie zu einem zentralen …

Räumlich-epidemiologische Datenanalyse von Pathologiedaten (REDPath)

In der pathologischen Routinediagnostik entstehen täglich große, gut dokumentierte Datensätze, deren Potential für räumlich-epidemiologische Analysen bislang kaum genutzt wird. Durch die Annotation dieser Daten eröffnen sich neue Möglichkeiten: …